This content is from: Premium Perceptive Gets a Big Boost From Pfizer’s Array Deal The healthcare and biotech specialist enjoyed hefty gains in many of its top holdings on Monday. By Stephen Taub June 18, 2019
This content is from: Premium Glenview Capital Posts Big Gains in June Larry Robbins’ fund is up for the year, despite heavy May losses. By Michelle Celarier July 16, 2019
This content is from: Corner Office Monica Lai Senior Investment Director at Sloan Foundation May 31, 2018
This content is from: Portfolio Allergan-Pfizer Merger Gives Pharma a Growth Injection The $160 billion all-stock deal is the largest-ever tax inversion and pharmaceutical sector merger. By Anne Szustek December 16, 2015
This content is from: Portfolio The 2015 Hedge Fund Rising Stars: Monica Lai At Pfizer, Lai oversees alternative investments for the pharmaceuticals giant’s $14 billion defined benefit pension plan. By Tyler Davies June 15, 2015
This content is from: Premium Hedge Funds Increase Health Care Bets Hedge fund managers upped their health care bets in the fourth quarter, according to a Goldman report. By Stephen Taub February 27, 2018
Sponsored Here's Where Asset Managers Can Find Growth Despite the pandemic and accompanying economic crisis, asset managers have opportunities nearly everywhere they look right in their own office. Sponsored by Northern Trust July 15, 2020
Sponsored Scaling to Innovative New Heights A quant shop pursues sophisticated and complex new strategies through systemization – and in a cost-efficient way. Sponsored by Systematica Investments July 13, 2020
